|
|
|
Medizinische Publikationen
HARTMANN, A., STAPF, C., HOFMEISTER, C., MOHR, J. P., SCIACCA, R. R., STEIN, B. M., FAULSTICH, A., & MAST, H. (2000). Determinants of Neurological Outcome After Surgery for Brain Arteriovenous Malformation. Stroke, 31(10), 2361-2364.
KOENNECKE, H. C., BERNARDING, J., BRAUN, J., FAULSTICH, A., HOFMEISTER, C., NOHR, R., LEISTNER, S., & MARX, P. (2001). Scattered Brain Infarct Pattern on Diffusion-Weighted Magnetic Resonance Imaging in Patients with Acute Ischemic Stroke. Cerebrovasc Dis, 11(3), 157-163.
SAPPOK, T., FAULSTICH, A., STUCKERT, E., KRUCK, H., MARX, P., & KOENNECKE, H. C. (2001). Compliance with secondary prevention of ischemic stroke: a prospective evaluation. Stroke, 32(8), 1884-1889.
HARTMANN, A., PILE-SPELLMAN, J., STAPF, C., SCIACCA, R. R., FAULSTICH, A., MOHR, J. P., SCHUMACHER, H. C., & MAST, H. (2002). Risk of Endovascular Treatment of Brain Arteriovenous Malformations. Stroke, 33(7), 1816-1820.
SEYFERT, S., KUNZMANN, V., SCHWERTFEGER, N., KOCH, H. C., & FAULSTICH, A. (2002). Determinants of lumbar CSF protein concentration. Journal of Neurology, 249, 1021-1026.
SEYFERT, S., & FAULSTICH, A. (2003). Is the blood-CSF barrier altered in disease? Acta Neurol Scand, 108(4), 252-256.
SEYFERT, S., BECHER, A., OHRING, R., & FAULSTICH, A. (2004). The permeability of the blood-CSF barrier in hydrocephalus, polyradiculitis, and meningitis. J Neurol, 251(3), 355-356.
SEYFERT, S., FAULSTICH, A., & MARX, P. (2004). What determines the CSF concentrations of albumin and plasma-derived IgG. J Neurol Sci, 219, 31-33.
|